These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Supplementation with anti-oxidants Vitamin C and E decreases cyclosporine A trough-levels in renal transplant recipients. de Vries AP; Oterdoom LH; Gans RO; Bakker SJ Nephrol Dial Transplant; 2006 Jan; 21(1):231-2. PubMed ID: 16115840 [No Abstract] [Full Text] [Related]
7. [Living-donor kidney transplantation in the cyclosporine era]. Campise M; Tarantino A; Berardinelli L; Finazzi S; Montagnino G; Rossini G; Scalamogna M; Cesana B; Ponticelli C G Ital Nefrol; 2002; 19(1):49-54. PubMed ID: 12165946 [TBL] [Abstract][Full Text] [Related]
8. Cyclosporine pharmacokinetic profiles in stable renal allograft recipients converting from Sandimmun to Neoral. Vathsala A; Lee WT; Jacob E; Woo KT Transplant Proc; 1996 Jun; 28(3):1324-6. PubMed ID: 8658678 [No Abstract] [Full Text] [Related]
9. Effects of nicardipine on blood cyclosporine levels in renal transplant patients. Guan D; Wang R; Lu J; Wang M; Xu C Transplant Proc; 1996 Jun; 28(3):1311-2. PubMed ID: 8658673 [No Abstract] [Full Text] [Related]
10. Interaction of lipids and cyclosporine. Morgenstern BZ; Murphy M; Milliner DS Transplant Proc; 1994 Feb; 26(1):130. PubMed ID: 8108906 [No Abstract] [Full Text] [Related]
12. Results of changing cyclosporine from twice to once daily dosing frequency. Hsieh H; Chen CH; Lai MK Transplant Proc; 1994 Aug; 26(4):1922-3. PubMed ID: 8066627 [No Abstract] [Full Text] [Related]
13. Impairment of DNA repair in the course of long-term hemodialysis and under cyclosporine immunosuppression after renal transplantation. Vamvakas S; Bahner U; Becker P; Steinle A; Götz R; Heidland A Transplant Proc; 1996 Dec; 28(6):3468-73. PubMed ID: 8962350 [No Abstract] [Full Text] [Related]
14. Is the vasoconstrictive effect of cyclosporine mediated by endothelin in kidney transplantation? Mouquet C; Benalia H; Carayon A; Bitker MO; Luciani J; Viars P Transplant Proc; 1994 Feb; 26(1):277-8. PubMed ID: 8108977 [No Abstract] [Full Text] [Related]
15. Effects of different calcineurin inhibitors on sex hormone levels in transplanted male patients. Kantarci G; Sahin S; Uras AR; Ergin H Transplant Proc; 2004; 36(1):178-9. PubMed ID: 15013339 [TBL] [Abstract][Full Text] [Related]
16. Drug interaction in a renal transplant patient: cyclosporin-Neoral and orlistat. Evans S; Michael R; Wells H; Maclean D; Gordon I; Taylor J; Goldsmith D Am J Kidney Dis; 2003 Feb; 41(2):493-6. PubMed ID: 12552515 [TBL] [Abstract][Full Text] [Related]
17. Clinical study of sandimmun neoral in cadaveric renal transplantation. Xue W; Chen Y; Xing J; Tian P Transplant Proc; 1996 Jun; 28(3):1333-4. PubMed ID: 8658682 [No Abstract] [Full Text] [Related]
18. Two cases of recurrent IgA nephropathy following kidney transplantation. Kishi Y; Takai K; Akao J; Isoyama N; Matsumura M; Uchiyama K; Tsuchida M; Suga A; Naito K Transplant Proc; 2004 Sep; 36(7):2160-1. PubMed ID: 15518785 [TBL] [Abstract][Full Text] [Related]
19. Rapidly progressive glomerulonephritis in a renal transplant with recurrent IgA nephropathy. Park SB; Joo I; Park KA; Cho WH; Park CH; Kim SP; Park KK; Kim HC Transplant Proc; 1996 Jun; 28(3):1529-30. PubMed ID: 8658772 [No Abstract] [Full Text] [Related]
20. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience. Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494 [No Abstract] [Full Text] [Related] [Next] [New Search]